Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Extracorporeal Membrane Oxygenation | 11 | 2022 | 182 | 2.090 |
Why?
|
Abnormalities, Multiple | 5 | 2013 | 234 | 1.200 |
Why?
|
Heart Defects, Congenital | 8 | 2022 | 363 | 1.120 |
Why?
|
Respiration, Artificial | 3 | 2015 | 352 | 0.770 |
Why?
|
Infant | 25 | 2022 | 3152 | 0.730 |
Why?
|
Parenchymal Tissue | 1 | 2020 | 6 | 0.710 |
Why?
|
Pleura | 1 | 2020 | 31 | 0.690 |
Why?
|
Infant, Newborn | 22 | 2022 | 2481 | 0.690 |
Why?
|
Pulmonary Artery | 4 | 2013 | 319 | 0.680 |
Why?
|
Hypoplastic Left Heart Syndrome | 4 | 2022 | 77 | 0.560 |
Why?
|
Heart Septal Defects, Ventricular | 3 | 2022 | 69 | 0.540 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 260 | 0.540 |
Why?
|
Aneurysm | 3 | 2007 | 60 | 0.530 |
Why?
|
Child, Preschool | 16 | 2020 | 3724 | 0.530 |
Why?
|
Cardiopulmonary Bypass | 4 | 2012 | 157 | 0.530 |
Why?
|
Heart-Assist Devices | 4 | 2015 | 757 | 0.480 |
Why?
|
Cineangiography | 1 | 2013 | 13 | 0.460 |
Why?
|
Tracheobronchomalacia | 1 | 2013 | 11 | 0.460 |
Why?
|
Vascular Malformations | 1 | 2013 | 19 | 0.450 |
Why?
|
Retrospective Studies | 22 | 2022 | 9034 | 0.450 |
Why?
|
Atrial Appendage | 1 | 2013 | 32 | 0.440 |
Why?
|
Hernias, Diaphragmatic, Congenital | 1 | 2013 | 14 | 0.440 |
Why?
|
Norwood Procedures | 2 | 2022 | 40 | 0.410 |
Why?
|
Intra-Abdominal Hypertension | 1 | 2012 | 5 | 0.410 |
Why?
|
Lactates | 2 | 2022 | 36 | 0.400 |
Why?
|
Heart Block | 1 | 2012 | 31 | 0.400 |
Why?
|
Heart Transplantation | 3 | 2015 | 717 | 0.400 |
Why?
|
Hemodynamics | 6 | 2022 | 730 | 0.390 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2010 | 67 | 0.370 |
Why?
|
Arrhythmias, Cardiac | 2 | 2012 | 199 | 0.370 |
Why?
|
Child | 15 | 2022 | 7158 | 0.350 |
Why?
|
Expectorants | 1 | 2009 | 6 | 0.340 |
Why?
|
Deoxyribonucleases | 1 | 2009 | 29 | 0.340 |
Why?
|
Pulmonary Atelectasis | 1 | 2009 | 18 | 0.340 |
Why?
|
Patient Transfer | 1 | 2010 | 94 | 0.320 |
Why?
|
Heart Failure | 2 | 2015 | 1183 | 0.320 |
Why?
|
Aorta | 2 | 2007 | 288 | 0.320 |
Why?
|
Registries | 1 | 2013 | 781 | 0.310 |
Why?
|
Treatment Outcome | 15 | 2022 | 8227 | 0.310 |
Why?
|
Female | 29 | 2022 | 46118 | 0.290 |
Why?
|
Tomography, X-Ray Computed | 3 | 2013 | 2659 | 0.280 |
Why?
|
Tetralogy of Fallot | 2 | 2012 | 44 | 0.280 |
Why?
|
Humans | 42 | 2023 | 89222 | 0.270 |
Why?
|
Critical Care | 1 | 2009 | 380 | 0.260 |
Why?
|
Pulmonary Atresia | 2 | 2004 | 12 | 0.250 |
Why?
|
Ductus Arteriosus | 2 | 2006 | 27 | 0.250 |
Why?
|
Decision Making | 1 | 2010 | 665 | 0.230 |
Why?
|
Male | 24 | 2022 | 42347 | 0.230 |
Why?
|
Time Factors | 7 | 2015 | 5336 | 0.230 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2023 | 15 | 0.220 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2023 | 33 | 0.210 |
Why?
|
Arteriovenous Malformations | 1 | 2023 | 45 | 0.210 |
Why?
|
Sodium Bicarbonate | 1 | 2022 | 9 | 0.210 |
Why?
|
Cardiac Surgical Procedures | 5 | 2013 | 475 | 0.200 |
Why?
|
Follow-Up Studies | 6 | 2015 | 3661 | 0.200 |
Why?
|
Cohort Studies | 5 | 2015 | 2866 | 0.190 |
Why?
|
Gestational Age | 4 | 2013 | 325 | 0.180 |
Why?
|
Propranolol | 2 | 2010 | 44 | 0.170 |
Why?
|
Cough | 1 | 2020 | 55 | 0.170 |
Why?
|
Hemangioma | 2 | 2010 | 64 | 0.170 |
Why?
|
Dyspnea | 1 | 2020 | 75 | 0.170 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 105 | 0.170 |
Why?
|
Fibrosis | 1 | 2020 | 234 | 0.160 |
Why?
|
Rhabdomyoma | 1 | 1998 | 3 | 0.160 |
Why?
|
Ultrasonography | 5 | 2013 | 711 | 0.160 |
Why?
|
Adolescent | 7 | 2010 | 9247 | 0.160 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2012 | 223 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 1998 | 63 | 0.150 |
Why?
|
Echocardiography | 5 | 2010 | 937 | 0.150 |
Why?
|
Heart Ventricles | 2 | 2022 | 779 | 0.140 |
Why?
|
Hospital Mortality | 3 | 2022 | 387 | 0.140 |
Why?
|
Injections, Intravenous | 2 | 2013 | 240 | 0.140 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2022 | 104 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2020 | 395 | 0.130 |
Why?
|
Acute-Phase Proteins | 1 | 2015 | 37 | 0.120 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2015 | 51 | 0.120 |
Why?
|
Antithrombin III | 1 | 2014 | 9 | 0.120 |
Why?
|
Antithrombins | 1 | 2014 | 16 | 0.120 |
Why?
|
Cardiac Catheterization | 2 | 2010 | 302 | 0.120 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 1721 | 0.110 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2013 | 54 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 266 | 0.110 |
Why?
|
Hernia, Diaphragmatic | 1 | 2013 | 10 | 0.110 |
Why?
|
Cyanosis | 1 | 2012 | 9 | 0.110 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 30 | 0.110 |
Why?
|
Constriction, Pathologic | 1 | 2013 | 217 | 0.110 |
Why?
|
Heparin | 1 | 2014 | 185 | 0.110 |
Why?
|
Mitral Valve Insufficiency | 1 | 2015 | 192 | 0.110 |
Why?
|
Cause of Death | 1 | 2014 | 266 | 0.110 |
Why?
|
Heart Septum | 1 | 2012 | 47 | 0.110 |
Why?
|
Intubation, Intratracheal | 1 | 2013 | 148 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2013 | 91 | 0.100 |
Why?
|
Ketamine | 1 | 2012 | 25 | 0.100 |
Why?
|
Femoral Vein | 1 | 2012 | 39 | 0.100 |
Why?
|
Respiration | 1 | 2013 | 267 | 0.100 |
Why?
|
Femoral Artery | 1 | 2012 | 83 | 0.100 |
Why?
|
Critical Illness | 2 | 2012 | 306 | 0.100 |
Why?
|
Risk Factors | 2 | 2015 | 5490 | 0.100 |
Why?
|
Hepacivirus | 1 | 2013 | 130 | 0.100 |
Why?
|
Jugular Veins | 1 | 2012 | 74 | 0.100 |
Why?
|
Peritoneal Dialysis | 1 | 2012 | 31 | 0.100 |
Why?
|
Survival Analysis | 3 | 2012 | 1534 | 0.100 |
Why?
|
Regression Analysis | 2 | 2010 | 590 | 0.100 |
Why?
|
Neuroprotective Agents | 1 | 2012 | 100 | 0.100 |
Why?
|
Career Choice | 1 | 2013 | 148 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2012 | 895 | 0.100 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2012 | 69 | 0.090 |
Why?
|
Carotid Arteries | 1 | 2012 | 134 | 0.090 |
Why?
|
Hospitals, Pediatric | 1 | 2012 | 116 | 0.090 |
Why?
|
Survival Rate | 3 | 2009 | 1900 | 0.090 |
Why?
|
Adrenal Insufficiency | 1 | 2010 | 23 | 0.090 |
Why?
|
Postoperative Period | 2 | 2022 | 302 | 0.090 |
Why?
|
Anticoagulants | 1 | 2014 | 427 | 0.090 |
Why?
|
Hospitals, Special | 1 | 2010 | 7 | 0.090 |
Why?
|
Tracheal Neoplasms | 1 | 2009 | 8 | 0.090 |
Why?
|
Brain Injuries | 1 | 2012 | 164 | 0.090 |
Why?
|
Length of Stay | 3 | 2022 | 733 | 0.090 |
Why?
|
Lymphopenia | 1 | 2009 | 31 | 0.080 |
Why?
|
Fetal Heart | 1 | 2009 | 13 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 345 | 0.080 |
Why?
|
Pulmonary Gas Exchange | 1 | 2009 | 32 | 0.080 |
Why?
|
Pulmonary Ventilation | 1 | 2009 | 33 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2563 | 0.080 |
Why?
|
Biomarkers | 4 | 2022 | 1764 | 0.080 |
Why?
|
Anesthesia, General | 1 | 2010 | 118 | 0.080 |
Why?
|
Contrast Media | 1 | 2013 | 1090 | 0.080 |
Why?
|
Program Evaluation | 1 | 2010 | 307 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2010 | 188 | 0.080 |
Why?
|
Risk Assessment | 2 | 2015 | 2301 | 0.080 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2007 | 9 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2007 | 241 | 0.080 |
Why?
|
Biliary Atresia | 1 | 2007 | 22 | 0.080 |
Why?
|
Dilatation, Pathologic | 1 | 2007 | 55 | 0.080 |
Why?
|
Chromosome Aberrations | 1 | 2009 | 390 | 0.070 |
Why?
|
Neutrophils | 1 | 2009 | 308 | 0.070 |
Why?
|
Vena Cava, Superior | 1 | 2007 | 60 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2009 | 1012 | 0.070 |
Why?
|
Fontan Procedure | 2 | 2007 | 56 | 0.070 |
Why?
|
Syndrome | 1 | 2007 | 449 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2007 | 66 | 0.070 |
Why?
|
Incidence | 3 | 2013 | 1593 | 0.070 |
Why?
|
Inflammation | 1 | 2012 | 971 | 0.070 |
Why?
|
Methicillin Resistance | 1 | 2006 | 32 | 0.070 |
Why?
|
Vena Cava, Inferior | 1 | 2007 | 145 | 0.070 |
Why?
|
Aneurysm, Ruptured | 1 | 2006 | 54 | 0.070 |
Why?
|
Heart Arrest | 1 | 2009 | 279 | 0.070 |
Why?
|
Developmental Disabilities | 1 | 2007 | 202 | 0.070 |
Why?
|
Bacteremia | 1 | 2006 | 102 | 0.060 |
Why?
|
Prenatal Diagnosis | 2 | 2009 | 110 | 0.060 |
Why?
|
Ultrasonography, Prenatal | 2 | 2009 | 152 | 0.060 |
Why?
|
Ebstein Anomaly | 1 | 2004 | 5 | 0.060 |
Why?
|
Stroke | 1 | 2013 | 986 | 0.060 |
Why?
|
Internship and Residency | 1 | 2013 | 1043 | 0.060 |
Why?
|
Staphylococcal Infections | 1 | 2006 | 271 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2009 | 1838 | 0.050 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2003 | 98 | 0.050 |
Why?
|
Vascular Resistance | 1 | 2022 | 101 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2010 | 1063 | 0.050 |
Why?
|
C-Reactive Protein | 2 | 2015 | 192 | 0.050 |
Why?
|
Pericardium | 1 | 2003 | 70 | 0.050 |
Why?
|
Pacemaker, Artificial | 1 | 2003 | 95 | 0.050 |
Why?
|
Bicarbonates | 1 | 2022 | 58 | 0.050 |
Why?
|
Gases | 1 | 2022 | 30 | 0.050 |
Why?
|
Autopsy | 2 | 2014 | 122 | 0.050 |
Why?
|
Reoperation | 2 | 2003 | 598 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2003 | 178 | 0.050 |
Why?
|
Aortic Valve | 1 | 2003 | 244 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2022 | 369 | 0.050 |
Why?
|
Arkansas | 2 | 2010 | 3 | 0.050 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2003 | 227 | 0.040 |
Why?
|
Young Adult | 2 | 2009 | 6301 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2000 | 242 | 0.040 |
Why?
|
Prevalence | 1 | 2023 | 1243 | 0.040 |
Why?
|
Pregnancy | 2 | 2009 | 3015 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2014 | 396 | 0.040 |
Why?
|
Tachycardia, Supraventricular | 1 | 1998 | 16 | 0.040 |
Why?
|
Heart Diseases | 1 | 2000 | 298 | 0.040 |
Why?
|
Thrombosis | 1 | 2000 | 302 | 0.040 |
Why?
|
Oxygen | 1 | 2022 | 742 | 0.040 |
Why?
|
Aortopulmonary Septal Defect | 1 | 1996 | 1 | 0.030 |
Why?
|
Lung | 1 | 2023 | 1259 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2000 | 1596 | 0.030 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1996 | 40 | 0.030 |
Why?
|
Age Factors | 1 | 2000 | 1868 | 0.030 |
Why?
|
Fibrinogen | 1 | 2015 | 53 | 0.030 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 1994 | 4 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 1996 | 167 | 0.030 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1994 | 33 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 3444 | 0.030 |
Why?
|
Norepinephrine | 1 | 1994 | 170 | 0.030 |
Why?
|
Adrenal Glands | 1 | 2014 | 77 | 0.030 |
Why?
|
Hyperbilirubinemia | 1 | 1993 | 21 | 0.030 |
Why?
|
Prospective Studies | 2 | 2012 | 4281 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 1994 | 433 | 0.030 |
Why?
|
Hip | 1 | 2012 | 18 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2013 | 298 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2012 | 69 | 0.030 |
Why?
|
Pulmonary Veins | 1 | 1993 | 93 | 0.030 |
Why?
|
Rotation | 1 | 2012 | 91 | 0.030 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2012 | 36 | 0.030 |
Why?
|
Hemorrhage | 1 | 2014 | 280 | 0.020 |
Why?
|
Body Height | 1 | 2012 | 100 | 0.020 |
Why?
|
Adult | 2 | 2009 | 26559 | 0.020 |
Why?
|
Patient Positioning | 1 | 2012 | 65 | 0.020 |
Why?
|
Central Nervous System | 1 | 2012 | 153 | 0.020 |
Why?
|
Linear Models | 1 | 2012 | 421 | 0.020 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2010 | 2 | 0.020 |
Why?
|
Body Weight | 1 | 2012 | 452 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2014 | 373 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2010 | 131 | 0.020 |
Why?
|
Child Development | 1 | 2012 | 167 | 0.020 |
Why?
|
Photography | 1 | 2010 | 37 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 1940 | 0.020 |
Why?
|
Infant, Premature | 1 | 2012 | 296 | 0.020 |
Why?
|
Vincristine | 1 | 2009 | 112 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2009 | 71 | 0.020 |
Why?
|
Laryngoscopy | 1 | 2009 | 47 | 0.020 |
Why?
|
Pilot Projects | 1 | 2012 | 868 | 0.020 |
Why?
|
Lactic Acid | 1 | 2009 | 92 | 0.020 |
Why?
|
Treatment Failure | 1 | 2009 | 287 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2009 | 101 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2010 | 302 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 360 | 0.020 |
Why?
|
Administration, Oral | 1 | 2010 | 682 | 0.020 |
Why?
|
Cytokines | 1 | 2012 | 802 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2012 | 1717 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2009 | 159 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 277 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2009 | 253 | 0.020 |
Why?
|
ROC Curve | 1 | 2009 | 781 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2006 | 64 | 0.020 |
Why?
|
Disease Progression | 1 | 2009 | 1488 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2010 | 2754 | 0.010 |
Why?
|
Infant Welfare | 1 | 2003 | 6 | 0.010 |
Why?
|
Washington | 1 | 2003 | 49 | 0.010 |
Why?
|
Tricuspid Atresia | 1 | 2003 | 4 | 0.010 |
Why?
|
Child Welfare | 1 | 2003 | 38 | 0.010 |
Why?
|
Pulmonary Valve | 1 | 2003 | 34 | 0.010 |
Why?
|
Heart Septal Defects | 1 | 2003 | 32 | 0.010 |
Why?
|
Polytetrafluoroethylene | 1 | 2003 | 74 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2003 | 198 | 0.010 |
Why?
|
Morbidity | 1 | 2003 | 149 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2003 | 177 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 2003 | 115 | 0.010 |
Why?
|
Thromboembolism | 1 | 2003 | 120 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2003 | 343 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 2010 | 2616 | 0.010 |
Why?
|
Brain | 1 | 2012 | 2281 | 0.010 |
Why?
|
Mitral Valve | 1 | 2003 | 262 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2003 | 996 | 0.010 |
Why?
|
Brimonidine Tartrate | 1 | 1994 | 1 | 0.010 |
Why?
|
Yohimbine | 1 | 1994 | 7 | 0.010 |
Why?
|
Prazosin | 1 | 1994 | 10 | 0.010 |
Why?
|
Muscle Relaxation | 1 | 1994 | 18 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1994 | 45 | 0.010 |
Why?
|
Quinoxalines | 1 | 1994 | 50 | 0.010 |
Why?
|
Arginine | 1 | 1994 | 138 | 0.010 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 1993 | 18 | 0.010 |
Why?
|
Nitric Oxide | 1 | 1994 | 279 | 0.010 |
Why?
|
Swine | 1 | 1994 | 581 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2003 | 2280 | 0.010 |
Why?
|
Portal Vein | 1 | 1993 | 120 | 0.010 |
Why?
|
Animals | 1 | 1994 | 27338 | 0.000 |
Why?
|